Stay updated on LITT with Checkpoint Inhibitor for RGBM Clinical Trial
Sign up to get notified when there's something new on the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page.

Latest updates to the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check23 days agoChange DetectedThe webpage has been updated to reflect a new version of the study on glioblastoma, including the addition of specific details about the study's design and objectives, while removing previous descriptions of the study's purpose and methodology.SummaryDifference62%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 7, 2025.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to v2.14.3, replacing the previous estimated update date of January 7, 2025, and revision v2.14.2.SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to LITT with Checkpoint Inhibitor for RGBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LITT with Checkpoint Inhibitor for RGBM Clinical Trial page.